Hims & Hers Health (NYSE:HIMS – Get Free Report) and Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.
Insider & Institutional Ownership
63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 13.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings and price targets for Hims & Hers Health and Strata Skin Sciences, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hims & Hers Health | 3 | 12 | 2 | 0 | 1.94 |
| Strata Skin Sciences | 1 | 0 | 0 | 0 | 1.00 |
Profitability
This table compares Hims & Hers Health and Strata Skin Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hims & Hers Health | 5.47% | 22.48% | 7.02% |
| Strata Skin Sciences | -35.64% | -476.73% | -33.49% |
Risk & Volatility
Hims & Hers Health has a beta of 2.43, indicating that its stock price is 143% more volatile than the S&P 500. Comparatively, Strata Skin Sciences has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500.
Valuation & Earnings
This table compares Hims & Hers Health and Strata Skin Sciences”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hims & Hers Health | $2.35 billion | 1.41 | $126.04 million | $0.51 | 28.44 |
| Strata Skin Sciences | $30.98 million | 0.05 | -$10.09 million | ($2.67) | -0.09 |
Hims & Hers Health has higher revenue and earnings than Strata Skin Sciences. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Summary
Hims & Hers Health beats Strata Skin Sciences on 13 of the 14 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
About Strata Skin Sciences
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
